The Bioassay laboratory (BL) is intended to serve as a national resource platform for the clinical development of vaccines and biologicals and aims to provide clinical assay services for vaccine-preventable pathogens as per the regulatory standards. The laboratory has currently established molecular and serological assays for Dengue and Chikungunya and is awaiting accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL) as per the ISO-17025:2017 standard. The laboratory is also validating virus neutralization assays for Dengue and Chikungunya and other mosquito-borne viruses for the next phase of accreditation. We are also an ICMR-recognized COVID-19 testing facility, the first one in Faridabad-Palwal region and have processed more than 42,000 clinical samples till date for diagnosis from several nearby districts to date. BL is also managing the mobile testing laboratory for COVID-19, the only one of its kind in India.
iLab: Infectious Disease Diagnostic Laboratory, funded by the Department of Biotechnology
THSTI Bioassay Laboratory is committed to achieve highest customer satisfaction through continual improvements, highest ethical standards and strive for achieving greater public good. This will be achieved by our total commitment to:
BL is involved in partnerships and collaborations with both national and international agencies such as International Centre for Genetic Engineering and Biotechnology, New Delhi; Indian Institute of Science, Bangalore; Christian Medical College, Vellore; Manipal Virus research Centre; International Vaccine Institute, South Korea.